Dr. Ying Huang presents first-in-human data for in vivo CAR-T LB2501 in B-cell NHL

He explains how this in vivo lentiviral vector infusion aims to eliminate traditional manufacturing barriers by shifting the cell engineering process directly into the patient's body. The post Dr. Ying Huang presents first-in-human data for in vivo CAR-T LB2501 in B-cell NHL appeared first on SOHO Insider .